Beneficial effects of Phellodendri Cortex extract on hyperglycemia and diabetic nephropathy in streptozotocin-induced diabetic rats

被引：36

作者：

Kim, Hye-Jeong ^{[1
]}

Kong, Min-Kyu ^{[1
]}

Kim, Young-Chul ^{[1
]}

机构：

[1] Keimyung Univ, Dept Publ Hlth, Taegu, South Korea

来源：

BMB REPORTS | 2008年 / 41卷 / 10期

关键词：

Antioxidant effect; Diabetic nephropathy; Diabetic rat; Phellodendri Cortex; Streptozotocin;

D O I：

10.5483/BMBRep.2008.41.10.710

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

This study investigated the effect of Phellodendri Cortex extract on hyperglycemia and diabetic nephropathy in streptozotocin-induced diabetic rats. Male Sprague-Dawley rats were divided into normal control (NO, diabetic control (DC), and diabetic treatment with Phellodendri Cortex extract (DP). Over a 4-week experimental period, Phellodendri Cortex extract was administered orally at 379 mg/kg BW/day. The final fasting senium glucose level, urine total protein level, and relative left kidney weight in the DP group were significantly lower than the DC group. Renal XO and SOD activities in the DIP group were significantly lower than the DC group and renal CAT activity in the DIP group was significantly higher than the DC group. Tubular epithelial change was reduced in the DP group compared to the DC group. These results indicated that Phelloclendri Cortex can reduce glucose level and prevent or retard the development of diabetic nephropathy in streptozotocin-incluced diabetic rats. [BMB reports 2008; 41(10): 710-715]

引用

页码：710 / 715

页数：6

共 29 条

[1] Aebi H., 1974, METHODS ENZYMATIC AN, VII
[2] Nordihydroguairetic acid, a lignin, prevents oxidative stress and the development of diabetic nephropathy in rats
Anjaneyulu, M
Chopra, K
[J]. PHARMACOLOGY, 2004, 72 (01) : 42 - 50
[3] ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES
BAYNES, JW
[J]. DIABETES, 1991, 40 (04) : 405 - 412
[4] THE HEXOKINASE AND PHOSPHOGLUCOISOMERASE ACTIVITIES OF AORTIC AND PULMONARY-ARTERY TISSUE IN INDIVIDUALS OF VARIOUS AGES
BRANDSTRUP, N
KIRK, JE
BRUNI, C
[J]. JOURNALS OF GERONTOLOGY, 1957, 12 (02): : 166 - 171
[5] Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension
Butler, R
Morris, AD
Belch, JJF
Hill, A
Struthers, AD
[J]. HYPERTENSION, 2000, 35 (03) : 746 - 751
[6] Chatterjea MN., 2002, TXB MED BIOCH, P317
[7] Deisseroth A., 1970, PHYSIOL REV, V50, P3
[8] DELMAESTRO RF, 1980, ACTA PHYSIOL SCAND, P153
[9] EDWARDS CRW, 1995, DAVIDSONS PRINCIPLES, P669
[10] FOSSATI P, 1983, CLIN CHEM, V29, P1494

← 1 2 3 →